Alivus Life Sciences Limited — Others, 27-11-2024: Shareholders meeting

Glenmark Life Sciences Limited has shared the results of its postal ballot, where shareholders voted on two special resolutions. Both resolutions—one for changing the company's name and another for alterations to the Memorandum and Articles of Association—were passed with a significant majority, securing over 99.99% approval. The outcome reflects strong shareholder confidence, which can bode well for the company’s strategic repositioning and operational plans. This decisive approval may enhance investor sentiment towards Glenmark, indicating a positive outlook as it moves forward with its initiatives.